Regulatory discrepancies and patient-safety risks from the continued marketing of withdrawn medicines in Ecuador, Colombia, and Peru (2014-2025).

Saved in:

Bibliographic Details
Title:	Regulatory discrepancies and patient-safety risks from the continued marketing of withdrawn medicines in Ecuador, Colombia, and Peru (2014-2025).
Authors:	Miranda A; Department of Preventive Medicine and Public Health, University of Seville, Seville, Spain.; Facultad de Ciencias, Escuela Superior Politécnica de Chimborazo, Riobamba, Ecuador., Lopez C; Colegio de Ciencias de la Salud, Universidad San Francisco de Quito USFQ, Quito, Ecuador., Santos S; Colegio de Ciencias de la Salud, Universidad San Francisco de Quito USFQ, Quito, Ecuador., Moncayo A; Colegio de Ciencias de la Salud, Universidad San Francisco de Quito USFQ, Quito, Ecuador., Morales F; Department of Preventive Medicine and Public Health, University of Seville, Seville, Spain.; Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, College of Science and Technology, Temple University, Philadelphia, PA, USA., Teran E; Colegio de Ciencias de la Salud, Universidad San Francisco de Quito USFQ, Quito, Ecuador.
Source:	Drug metabolism and personalized therapy [Drug Metab Pers Ther] 2026 Mar 13. Date of Electronic Publication: 2026 Mar 13.
Publication Type:	Journal Article
Journal Info:	Publisher: De Gruyter Country of Publication: Germany NLM ID: 101653409 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2363-8915 (Electronic) Linking ISSN: 23638915 NLM ISO Abbreviation: Drug Metab Pers Ther Subsets: MEDLINE
Database:	MEDLINE Ultimate

Description
ISSN:	2363-8915
DOI:	10.1515/dmpt-2025-0081